Eli Lilly (LLY) earnings Q4 2025

Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025. Antranik Tavitian | Reuters Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soars. The pharmaceutical giant…

Read Full News

Chipotle (CMG) Q4 2025 earnings

The New York Stock Exchange welcomes executives and guests of Chipotle (NYSE: CMG) to the podium, on Friday, December 12, 2025, to celebrate the milestone of 4,000 restaurants. To honor the occasion, Scott Boatwright, CEO, joined by Chris Taylor, Chief Development Officer, NYSE, rings The Opening Bell®. Chipotle Mexican Grill on Tuesday reported quarterly earnings…

Read Full News

PepsiCo (PEP) Q4 2025 earnings

PepsiCo on Tuesday reported quarterly earnings and revenue that topped analysts’ expectations, fueled by improving organic sales across its business. Demand for the company’s snacks has been sluggish as consumers balk at higher prices. This year, Pepsi plans to lower prices on products like chips from its North American food division to “improve competitiveness and the purchase…

Read Full News

Pfizer (PFE) earnings Q4 2025

Albert Bourla, CEO of Pfizer, speaking on Squawk on the Street at the World Economic Forum in Davos, Switzerland on Jan. 20, 2026. Oscar Molina | CNBC Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while reaffirming its modest 2026 guidance that rattled investors in December….

Read Full News